| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1230.7% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 71.9 | n/a |
| Pr/Book | 41.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 88.6% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1.79 | (16.27) | (23.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 2.57 | (50.08) | (63.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.64 | (19.37) | (10.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 1.20 | (14.41) | (7.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Cambridge’s Papworth Hospital Pilots Steri... | 02-Oct-2025 | 07:00 | RNS |
| Ondine Biomedical Continues Growth in H1 2025 | 26-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results & Investor Presentation | 19-Sep-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 12.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 18.00 |
| 52 Week Low | 6.63 |
| Volume | 1,078,919 |
| Shares Issued | 517.57m |
| Market Cap | £64.70m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:08 | 84,500 @ 12.50p |
| 14:52 | 33,997 @ 12.10p |
| 11:38 | 100,000 @ 12.60p |
| 11:31 | 1,044 @ 13.00p |
| 11:31 | 450,000 @ 13.00p |
| Chair | Jean Charest |
| CEO | Carolyn Cross |
You are here: research